2016
DOI: 10.1590/s1518-8787.2016050006118
|View full text |Cite
|
Sign up to set email alerts
|

Abstract: OBJECTIVE To analyze the free access to medicines for the treatment of chronic diseases in the Brazilian population, according to demographic and socioeconomic factors. We also analyzed the most used pharmacological groups, according to funding source: free-of-charge or out-of-pocket paid.METHODS Analysis of data from the Pesquisa Nacional sobre Acesso, Utilização e Promoção do Uso Racional de Medicamentos (PNAUM – National Survey on Access, Use and Promotion of Rational Use of Medicines), a population-based h… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

4
32
1
6

Year Published

2016
2016
2023
2023

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 33 publications
(43 citation statements)
references
References 23 publications
4
32
1
6
Order By: Relevance
“…For other NCDs, free access was not as broad, as pointed out by Tavares et al in another PNAUM study (48%). 48 However, the data show some regional weaknesses in access to medication in the country, with greater vulnerability in the Midwest and North regions. Thus, these gaps should be observed with new studies in an attempt to find solutions to reduce regional inequities.…”
Section: Discussionmentioning
confidence: 95%
“…For other NCDs, free access was not as broad, as pointed out by Tavares et al in another PNAUM study (48%). 48 However, the data show some regional weaknesses in access to medication in the country, with greater vulnerability in the Midwest and North regions. Thus, these gaps should be observed with new studies in an attempt to find solutions to reduce regional inequities.…”
Section: Discussionmentioning
confidence: 95%
“…There was a statistically significant association (p=0.004) between paid occupation and "Difficulty with prescribed regimen". In the context of chronic noncommunicable diseases, the higher the patient's income, the easier it is to follow the prescribed diet (19) . In this sense, the per capita income of people with celiac disease represents an essential characteristic for the success of their treatment, since products that are certainly free of gluten have a superior value when compared to those that do not contain it (20) .…”
Section: Discussionmentioning
confidence: 99%
“…Esses resultados estão em consonância com estudos prévios da PNAUM 15,41 quando se trata de outras DCNT. Para doenças respiratórias crônicas, no entanto, foi possível confirmar o que foi previamente reportado por Tavares et al 16 , que verificaram que medicamentos para o sistema respiratório haviam sido, na sua maioria, pagos com recursos do paciente, tanto aqueles para tratamento de doenças obstrutivas das vias aéreas (60%; IC95%: 52,7-66,9) quanto para o uso de anti-histamínicos sistêmicos (56,6%; IC95%: 43,3-69,1) 16 . Neste estudo, embora os usuários reportem elevado acesso aos medicamentos para doenças respiratórias crônicas, estes medicamentos são, em geral, pagos pelos próprios usuários, independentemente da classe econômica.…”
Section: Discussionunclassified
“…O manejo dos fatores de risco modificáveis, como redução do consumo de tabaco e a disponibilização de medicamentos, é uma iniciativa recomendada pela Organização Mundial da Saúde (OMS), a fim de minimizar agravos à saúde devido a essas doenças 10,13 . No entanto, o impacto do gasto com medicamentos, as limitações orçamentárias e o aumento dos gastos com saúde vinculados ao envelhecimento da população, fazem com que seja necessário otimizar os investimentos nessa área 14,15,16,17,18 . Além disso, a avaliação de forma criteriosa dos desfechos de saúde vinculados a essas intervenções também se faz necessária.…”
Section: Introductionunclassified